Innovation and worldwide deployment of Precision Oncology were the aspirational goals of our late and greatly missed Dr. John Mendelsohn, founder and chairman of WIN, Prof. Thomas Tursz, founder and vice chairman of WIN and Prof. Waun Ki Hong, special advisor to WIN for lung cancer.
We are proud to provide leadership to the WIN Consortium as chairman and vice-chairman and are excited about the challenge and privilege to continue the work started by these great giants in oncology.
We warmly invite you to attend the 12th Annual WIN Symposium that will take place on 21-22 June, 2020 in Barcelona, Spain.
As always, the WIN 2020 Symposium will gather renowned experts in personalized cancer medicine from all across the world and will explore in particular innovative ways to bolster precision oncology by integrating transcriptomics to the current armamentarium of genomics. More details will follow on our topics and speakers. So please stay tuned!
Your attendance will also be an invaluable opportunity to engage and network with all the different parties attending this year's symposium, from academia, industry, non-profit and patient advocacy.
Richard L. Schilsky
MD, FACP, FSCT, FASCO
Chairman, WIN Consortium, Executive Vice President & Chief Medical Officer, American Society of Clinical Oncology (ASCO)
Vice Chairman, WIN Consortium Head, Medical Oncology Department, Vall d’Hebron Institute of Oncology, President 2019, European Society for Medical Oncology (ESMO)
WIN 2021 Symposium
c/o MCI UK Ltd